Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach.
DISCUSSION: These virtual patient simulations, once validated against clinical data, could lead to better informed future clinical trial designs.
PMID: 32255562 [PubMed - as supplied by publisher]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
More News: Alzheimer's | Clinical Trials | Drugs & Pharmacology | Learning | Psychiatry | Universities & Medical Training